GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of glucagon: what the trials say vs what this community says — 31 comments in the full submission. View in context.
5k
c/retatrutide·submitted 1 year ago by u/solene_ilunga

glucagon: what the trials say vs what this community says

Cautionbranch of 8 comments

glucagon: what the trials say vs what this community says, and I am aware this is a minority view on this board. Where the evidence actually stands, since every thread here assumes a different answer. Phase 2 reported a large mean body weight change at 48 weeks across a few hundred participants with a slow,…

Read the full submission and all 31 comments →

This branch

8 comments, started 1 year ago
u/ewan_marchand90 points·1 year ago

Increases in heart rate have been reported across this receptor class. The magnitude and clinical significance are exactly what phase 3 is powered to establish.

replysharereportpermalink
u/endotoxin_elliemicro35 points·1 year ago

small trial, big effect, wide error bars

replysharereportpermalink
u/ewan_marchand15 points·1 year ago

heart rate is the thing people report watching

replysharereportpermalink
u/quiet_moderatormod21 points·1 year ago·edited

small trial, big effect, wide error bars

Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.

replysharereportpermalink
u/sofia_wikstrom5 points·1 year ago

the phase 2 numbers were striking and they were also 48 weeks in a small population

replysharereportpermalink
u/heart_rate_bump3 points·1 year ago

the phase 2 numbers were striking and they were also 48 weeks in a small population

Agreed, and the glucagon arm is exactly why the comparison threads do not work.

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.